Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
TYK2 | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 1.38E3 | Evidence | |||||
TYK2 | CSK | CSK: Tyrosine-protein kinase CSK | 1.17E3 | Evidence | |||||
TYK2 | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 1.17E3 | Evidence | |||||
TYK2 | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 835.0 | Evidence | |||||
TYK2 | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 720.0 | Evidence | |||||
TYK2 | SYK | SYK: Tyrosine-protein kinase SYK | 720.0 | Evidence | |||||
TYK2 | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 626.0 | Evidence | |||||
TYK2 | LYN | LYN: Tyrosine-protein kinase Lyn | 613.0 | Evidence | |||||
TYK2 | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 613.0 | Evidence | |||||
TYK2 | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 613.0 | Evidence | |||||
TYK2 | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 506.0 | Evidence | |||||
TYK2 | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 497.0 | Evidence | |||||
TYK2 | DOCK2 | DOCK2, KIAA0209: Dedicator of cytokinesis protein 2 | 445.0 | Evidence | |||||
TYK2 | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 416.0 | Evidence | |||||
TYK2 | NCK2 | NCK2: Cytoplasmic protein NCK2 | 407.0 | Evidence | |||||
TYK2 | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 392.0 | Evidence | |||||
TYK2 | HCK | N/A | 370.0 | Evidence | |||||
TYK2 | SLA | SLA, SLAP, SLAP1: SRC-like-adapter | 370.0 | Evidence | |||||
TYK2 | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 364.0 | Evidence | |||||
TYK2 | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 299.0 | Evidence | |||||
TYK2 | CRKL | CRKL: Crk-like protein | 268.0 | Evidence | |||||
TYK2 | JAK1 | 268.0 | Evidence | ||||||
TYK2 | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 263.0 | Evidence | |||||
TYK2 | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 221.0 | Evidence | |||||
TYK2 | KIT | KIT: Mast/stem cell growth factor receptor precursor | 206.0 | Evidence | |||||
TYK2 | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 194.0 | Evidence | |||||
TYK2 | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 178.0 | Evidence | |||||
TYK2 | STAT2 | STAT2: Signal transducer and activator of transcription 2 | 165.0 | Evidence | |||||
TYK2 | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 162.0 | Evidence | |||||
TYK2 | APS | SH2B2, APS: SH2B adapter protein 2 | 161.0 | Evidence | |||||
TYK2 | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 149.0 | Evidence | |||||
TYK2 | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 149.0 | Evidence | |||||
TYK2 | HCLS1 | HCLS1, HS1: Hematopoietic lineage cell-specific protein | 148.0 | Evidence | |||||
TYK2 | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 139.0 | Evidence | |||||
TYK2 | SOCS3 | SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 | 137.0 | Evidence | |||||
TYK2 | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 137.0 | Evidence | |||||
TYK2 | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 135.0 | Evidence | |||||
TYK2 | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 134.0 | Evidence | |||||
TYK2 | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 121.0 | Evidence | |||||
TYK2 | STAT3 | 119.0 | Evidence | ||||||
TYK2 | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 119.0 | Evidence | |||||
TYK2 | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 106.0 | Evidence | |||||
TYK2 | WASPIP | N/A | 101.0 | Evidence | |||||
TYK2 | DOK1 | DOK1: Docking protein 1 | 91.10 | Evidence | |||||
TYK2 | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 90.80 | Evidence | |||||
TYK2 | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 87.80 | Evidence | |||||
TYK2 | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 80.00 | Evidence | |||||
TYK2 | INSR | INSR: Insulin receptor precursor | 80.00 | Evidence | |||||
TYK2 | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 79.90 | Evidence | |||||
TYK2 | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 79.40 | Evidence | |||||
TYK2 | SNX17 | SNX17, KIAA0064: Sorting nexin-17 | 69.40 | Evidence | |||||
TYK2 | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 69.40 | Evidence | |||||
TYK2 | TEK | TEK, TIE2: Angiopoietin-1 receptor precursor | 59.50 | Evidence | |||||
TYK2 | CBLC | CBLC, CBL3, RNF57: Signal transduction protein CBL-C | 58.60 | Evidence | |||||
TYK2 | GRAP | GRAP: GRB2-related adapter protein | 55.80 | Evidence | |||||
TYK2 | EPHB3 | EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor | 53.30 | Evidence | |||||
TYK2 | PSMA5 | PSMA5: Proteasome subunit alpha type-5 | 53.3 | Evidence | |||||
TYK2 | PSMA3 | PSMA3, PSC8: Proteasome subunit alpha type-3 | 53.3 | Evidence | |||||
TYK2 | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 52.50 | Evidence | |||||
TYK2 | MAP4K1 | MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 | 46.90 | Evidence | |||||
TYK2 | PIK3CG | PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i | 46.90 | Evidence | |||||
TYK2 | PSMA2 | PSMA2, PSC3: Proteasome subunit alpha type-2 | 43.00 | Evidence | |||||
TYK2 | MAPK1 | MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 | 42.00 | Evidence | |||||
TYK2 | HGS | HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate | 36.30 | Evidence | |||||
TYK2 | NMT1 | NMT1, NMT: Glycylpeptide N-tetradecanoyltransferase 1 | 35.00 | Evidence | |||||
TYK2 | ACTG1 | ACTB: Actin, cytoplasmic 1 | 35.00 | Evidence | |||||
TYK2 | NRBP1 | NRBP1, BCON3, NRBP: Nuclear receptor-binding protein | 33.90 | Evidence | |||||
TYK2 | HNRPK | N/A | 32.90 | Evidence | |||||
TYK2 | CXCR4 | CXCR4: C-X-C chemokine receptor type 4 | 32.70 | Evidence | |||||
TYK2 | TGFB1 | TGFB1, TGFB: Transforming growth factor beta-1 precursor | 28.90 | Evidence | |||||
TYK2 | MAP3K8 | MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 | 27.90 | Evidence | |||||
TYK2 | SCAP2 | SKAP2, PRAP, RA70, SAPS, SCAP2, SKAP55R: Src kinase-associated phosphoprotein 2 | 26.70 | Evidence | |||||
TYK2 | ARHGDIB | ARHGDIB, GDIA2, GDID4, RAP1GN1: Rho GDP-dissociation inhibitor 2 | 25.00 | Evidence | |||||
TYK2 | QARS | QARS: Glutaminyl-tRNA synthetase | 25.00 | Evidence | |||||
TYK2 | TUBA1 | TUBA4A, TUBA1: Tubulin alpha-4A chain | 24.90 | Evidence | |||||
TYK2 | CSF2RB | CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor | 24.90 | Evidence | |||||
TYK2 | SOCS1 | SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 | 24.90 | Evidence | |||||
TYK2 | GAK | GAK: Cyclin G-associated kinase | 24.60 | Evidence | |||||
TYK2 | ITGAE | ITGAE: Integrin alpha-E precursor | 23.00 | Evidence | |||||
TYK2 | PASK | PASK, KIAA0135: PAS domain-containing serine/threonine-protein kinase | 22.80 | Evidence | |||||
TYK2 | HLA-F | HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec | 21.00 | Evidence | |||||
TYK2 | CDK2 | CDK2: Cell division protein kinase 2 | 20.50 | Evidence | |||||
TYK2 | PRKDC | PRKDC, HYRC, HYRC1: DNA-dependent protein kinase catalytic subunit | 19.10 | Evidence | |||||
TYK2 | PRKCQ | PRKCQ, PRKCT: Protein kinase C theta type | 16.20 | Evidence | |||||
TYK2 | CD22 | CD22, SIGLEC2: B-cell receptor CD22 precursor | 15.00 | Evidence | |||||
TYK2 | CDC2 | CDC2: Cell division control protein 2 homolog | 15.00 | Evidence | |||||
TYK2 | SNCA | SNCA, NACP, PARK1: Alpha-synuclein | 15.00 | Evidence | |||||
TYK2 | DNM3 | DNM3: Uncharacterized protein DNM3 | 15.00 | Evidence | |||||
TYK2 | PECAM1 | PECAM1: Platelet endothelial cell adhesion molecule precursor | 14.50 | Evidence | |||||
TYK2 | GRB7 | GRB7: Growth factor receptor-bound protein 7 | 14.20 | Evidence | |||||
TYK2 | PRKAA1 | N/A | 13.80 | Evidence | |||||
TYK2 | GAB1 | GAB1: GRB2-associated-binding protein 1 | 13.80 | Evidence | |||||
TYK2 | NEK3 | NEK3: Serine/threonine-protein kinase Nek3 | 13.80 | Evidence | |||||
TYK2 | AKT3 | AKT3: RAC-gamma serine/threonine-protein kinase | 13.40 | Evidence | |||||
TYK2 | LATS1 | LATS1, WARTS: Serine/threonine-protein kinase LATS1 | 13.40 | Evidence | |||||
TYK2 | NEDD9 | NEDD9, CASL: Enhancer of filamentation 1 | 13.40 | Evidence | |||||
TYK2 | RHOA | RHOA, ARH12, ARHA, RHO12: Transforming protein RhoA precursor | 13.10 | Evidence | |||||
TYK2 | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 12.40 | Evidence | |||||
TYK2 | EPOR | EPOR: Erythropoietin receptor precursor | 11.90 | Evidence | |||||
TYK2 | PPP1R12A | PPP1R12A, MBS, MYPT1: Protein phosphatase 1 regulatory subunit 12A | 11.70 | Evidence | |||||
TYK2 | RPS3 | RPS3, OK/SW-cl.26: 40S ribosomal protein S3 | 11.70 | Evidence | |||||
TYK2 | STAG2 | STAG2, SA2: Cohesin subunit SA-2 | 11.70 | Evidence | |||||
TYK2 | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 11.60 | Evidence | |||||
TYK2 | IL2RB | IL2RB: Interleukin-2 receptor subunit beta precursor | 11.40 | Evidence | |||||
TYK2 | CD79A | CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain | 11.40 | Evidence | |||||
TYK2 | IRS4 | IRS4, RP6-24A23.4-001, hCG_20762: Insulin receptor substrate 4 | 11.20 | Evidence | |||||
TYK2 | VAV1 | VAV1, VAV: Proto-oncogene vav | 11.10 | Evidence | |||||
TYK2 | TYRO3 | TYRO3, BYK, DTK, RSE, SKY: Tyrosine-protein kinase receptor TYRO3 precursor | 10.40 | Evidence | |||||
TYK2 | IL4R | IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor | 9.92 | Evidence | |||||
TYK2 | LAT | LAT: Linker for activation of T-cells family member 1 | 9.92 | Evidence | |||||
TYK2 | IL6ST | IL6ST: Interleukin-6 receptor subunit beta precursor | 9.92 | Evidence | |||||
TYK2 | FCGR2B | FCGR2B, CD32, FCG2, IGFR2: Low affinity immunoglobulin gamma Fc region receptor | 9.92 | Evidence | |||||
TYK2 | CD79B | CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p | 9.92 | Evidence | |||||
TYK2 | TRPV4 | TRPV4, VRL2, VROAC: Transient receptor potential cation channel subfamily V memb | 9.92 | Evidence | |||||
TYK2 | PTPRC | PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ | 9.92 | Evidence | |||||
TYK2 | IRS1 | IRS1: Insulin receptor substrate 1 | 9.89 | Evidence | |||||
TYK2 | IL10RB | IL10RB, CRFB4, D21S58, D21S66: Interleukin-10 receptor beta chain precursor | 9.84 | Evidence | |||||
TYK2 | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 9.37 | Evidence | |||||
TYK2 | IFNAR1 | IFNAR1, IFNAR: Interferon-alpha/beta receptor alpha chain precursor | 9.14 | Evidence | O | ||||
TYK2 | GHR | GHR: Growth hormone receptor precursor | 9.14 | Evidence | |||||
TYK2 | PARD6A | PARD6A, PAR6A: Partitioning defective 6 homolog alpha | 8.92 | Evidence | |||||
TYK2 | RANGAP1 | RANGAP1, SD: Ran GTPase-activating protein 1 | 8.84 | Evidence | |||||
TYK2 | TNKS2 | TNKS2, PARP5B, TANK2, TNKL: Tankyrase-2 | 8.81 | Evidence | |||||
TYK2 | PSMA6 | PSMA6, PROS27: Proteasome subunit alpha type-6 | 8.65 | Evidence | |||||
TYK2 | CD36 | CD36, GP3B, GP4: Platelet glycoprotein 4 | 8.31 | Evidence | |||||
TYK2 | DNM2 | N/A | 7.93 | Evidence | |||||
TYK2 | UBAP2L | UBAP2L, KIAA0144, NICE4: Ubiquitin-associated protein 2-like | 7.93 | Evidence | |||||
TYK2 | DAPP1 | N/A | 7.93 | Evidence | |||||
TYK2 | HNRPK | HNRPK, HNRNPK: Heterogeneous nuclear ribonucleoprotein K | 7.59 | Evidence | |||||
TYK2 | MTMR6 | MTMR6: Myotubularin-related protein 6 | 7.18 | Evidence | |||||
TYK2 | ACTB | ACTG1, ACTB, ACTG: Actin, cytoplasmic 2 | 6.83 | Evidence | |||||
TYK2 | PRKX | PRKX, PKX1: Serine/threonine-protein kinase PRKX | 6.78 | Evidence | |||||
TYK2 | MTMR1 | MTMR1: Myotubularin-related protein 1 | 6.78 | Evidence | |||||
TYK2 | MRCL3 | MRLC2, MLCB, RLC: Myosin regulatory light chain 2, nonsarcomeric | 6.78 | Evidence | |||||
TYK2 | XRCC6 | XRCC6, G22P1: ATP-dependent DNA helicase 2 subunit 1 | 6.71 | Evidence | |||||
TYK2 | PRLR | PRLR: Prolactin receptor precursor | 6.62 | Evidence | |||||
TYK2 | ITGB4 | N/A | 6.52 | Evidence | |||||
TYK2 | CDC42EP1 | CDC42EP1, BORG5, CEP1, MSE55: Cdc42 effector protein 1 | 6.14 | Evidence | |||||
TYK2 | PABPN1 | PABPN1, PAB2, PABP2: Polyadenylate-binding protein 2 | 6.01 | Evidence | |||||
TYK2 | SFRS2 | SFRS2: Splicing factor, arginine/serine-rich 2 | 6.01 | Evidence | |||||
TYK2 | PPP1R8 | N/A | 6.01 | Evidence | |||||
TYK2 | DHX16 | DHX16, DBP2, DDX16, KIAA0577: Putative pre-mRNA-splicing factor ATP-dependent RN | 6.01 | Evidence | |||||
TYK2 | FCER1G | FCER1G: High affinity immunoglobulin epsilon receptor subunit gamma precursor | 5.95 | Evidence | |||||
TYK2 | ASB8 | ASB8, PP14212: Ankyrin repeat and SOCS box protein 8 | 5.92 | Evidence | |||||
TYK2 | AGTR1 | AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor | 5.88 | Evidence | |||||
TYK2 | PTPN11 | N/A | 5.74 | Evidence | |||||
TYK2 | RPA2 | RPA2, REPA2, RPA32, RPA34: Replication protein A 32 kDa subunit | 5.74 | Evidence | |||||
TYK2 | YWHAZ | YWHAZ: 14-3-3 protein zeta/delta | 5.74 | Evidence | |||||
TYK2 | CASP3 | CASP3, CPP32: Caspase-3 precursor | 5.55 | Evidence | |||||
TYK2 | BCAR1 | BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 | 5.50 | Evidence | |||||
TYK2 | TUBB2A | TUBB2A, TUBB2: Tubulin beta-2A chain | 5.27 | Evidence | |||||
TYK2 | PSMA4 | PSMA4, PSC9: Proteasome subunit alpha type-4 | 5.23 | Evidence | |||||
TYK2 | ZYX | ZYX: Zyxin | 5.08 | Evidence | |||||
TYK2 | PTPN7 | PTPN7: Tyrosine-protein phosphatase non-receptor type 7 | 4.84 | Evidence | |||||
TYK2 | BFAR | BFAR, BAR, RNF47: Bifunctional apoptosis regulator | 4.80 | Evidence | |||||
TYK2 | IGHE | IGHE: Ig epsilon chain C region | 4.68 | Evidence | |||||
TYK2 | PLAUR | PLAUR, MO3, UPAR: Urokinase plasminogen activator surface receptor precursor | 4.48 | Evidence | |||||
TYK2 | GRIA3 | GRIA3, GLUR3, GLURC: Glutamate receptor 3 precursor | 4.01 | Evidence | |||||
TYK2 | CREBBP | CREBBP, CBP: CREB-binding protein | 3.85 | Evidence | |||||
TYK2 | RANBP1 | RANBP1: Ran-specific GTPase-activating protein | 3.69 | Evidence | |||||
TYK2 | NFATC3 | NFATC3, NFAT4: Nuclear factor of activated T-cells, cytoplasmic 3 | 3.64 | Evidence | |||||
TYK2 | GTF2B | GTF2B, TF2B, TFIIB: Transcription initiation factor IIB | 3.64 | Evidence | |||||
TYK2 | EVL | N/A | 3.47 | Evidence | |||||
TYK2 | TTN | TTN: Uncharacterized protein TTN (Fragment) | 3.44 | Evidence | |||||
TYK2 | SREBF2 | N/A | 3.28 | Evidence | |||||
TYK2 | ZNF217 | ZNF217, ZABC1: Zinc finger protein 217 | 3.28 | Evidence | |||||
TYK2 | STOM | STOM, BND7, EPB72: Erythrocyte band 7 integral membrane protein | 3.26 | Evidence | |||||
TYK2 | GUCA1C | GUCA1C, GCAP3: Guanylyl cyclase-activating protein 3 | 3.18 | Evidence | |||||
TYK2 | AQP2 | AQP2: Aquaporin-2 | 3.18 | Evidence | |||||
TYK2 | SHC2 | N/A | 3.08 | Evidence | |||||
TYK2 | RPS6KA6 | RPS6KA6, RSK4: Ribosomal protein S6 kinase alpha-6 | 2.97 | Evidence | |||||
TYK2 | IREB2 | IREB2: Iron-responsive element-binding protein 2 | 2.94 | Evidence | |||||
TYK2 | CTLA4 | CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor | 2.77 | Evidence | |||||
TYK2 | TXN | TXN, TRDX, TRX, TRX1: Thioredoxin | 2.63 | Evidence | |||||
TYK2 | STUB1 | STUB1, CHIP, PP1131: STIP1 homology and U box-containing protein 1 | 2.63 | Evidence | |||||
TYK2 | NPR3 | N/A | 2.62 | Evidence | |||||
TYK2 | MATK | 2.54 | Evidence | ||||||
TYK2 | CDC42 | N/A | 2.54 | Evidence | |||||
TYK2 | CASP9 | CASP9, MCH6: Caspase-9 precursor | 2.54 | Evidence | |||||
TYK2 | NASP | NASP: Nuclear autoantigenic sperm protein | 2.54 | Evidence | |||||
TYK2 | SLC4A1 | SLC4A1, AE1, DI, EPB3: Band 3 anion transport protein | 2.43 | Evidence | |||||
TYK2 | CAPN12 | CAPN12: Calpain-12 | 2.43 | Evidence | |||||
TYK2 | FCGR2A | FCGR2A: Fc of IgG, low affinity IIa, receptor | 2.42 | Evidence | |||||
TYK2 | RHOG | RHOG, ARHG: Rho-related GTP-binding protein RhoG precursor | 2.29 | Evidence | |||||
TYK2 | BCR | N/A | 2.28 | Evidence | |||||
TYK2 | LTA4H | LTA4H, LTA4: Leukotriene A-4 hydrolase | 2.28 | Evidence | |||||
TYK2 | GIT2 | N/A | 2.28 | Evidence | |||||
TYK2 | PDE8B | PDE8B: High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodies | 2.28 | Evidence | |||||
TYK2 | CASP7 | N/A | 2.28 | Evidence | |||||
TYK2 | RAC1 | N/A | 2.28 | Evidence | |||||
TYK2 | DOK3 | N/A | 2.17 | Evidence | |||||
TYK2 | SIRT1 | SIRT1, SIR2L1: NAD-dependent deacetylase sirtuin-1 | 2.17 | Evidence | |||||
TYK2 | CRK | N/A | 2.10 | Evidence | |||||
TYK2 | SHC1 | SHC1, RP11-307C12.1-001, hCG_1997126: SHC | 2.10 | Evidence | |||||
TYK2 | CD19 | N/A | 1.98 | Evidence | |||||
TYK2 | GRAP2 | GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 | 1.72 | Evidence | |||||
TYK2 | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 1.72 | Evidence | |||||
TYK2 | IKBKB | IKBKB, IKKB: Inhibitor of nuclear factor kappa-B kinase subunit beta | 1.57 | Evidence | |||||
TYK2 | PIK3CD | PIK3CD: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta i | 1.57 | Evidence | |||||
TYK2 | CD48 | CD48, BCM1, BLAST1: CD48 antigen precursor | 1.41 | Evidence | |||||
TYK2 | TAOK3 | TAOK3, DPK, JIK, KDS, MAP3K18: Serine/threonine-protein kinase TAO3 | 1.41 | Evidence | |||||
TYK2 | PRPF4B | PRPF4B, KIAA0536, PRP4, PRP4H, PRP4K: Serine/threonine-protein kinase PRP4 homol | 1.41 | Evidence | |||||
TYK2 | FNBP1 | N/A | 1.41 | Evidence | |||||
TYK2 | LCP1 | LCP1, PLS2: Plastin-2 | 1.41 | Evidence | |||||
TYK2 | SH2D2A | SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A | 1.30 | Evidence | |||||
TYK2 | PLCG1 | PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 | 1.30 | Evidence | |||||
TYK2 | SNAP23 | SNAP23: Synaptosomal-associated protein 23 | 1.30 | Evidence | |||||
TYK2 | FLT3 | FLT3, STK1: FL cytokine receptor precursor | 1.29 | Evidence | |||||
TYK2 | FXYD5 | FXYD5, DYSAD, HSPC113, IWU1, UNQ2561/PRO6241: FXYD domain-containing ion transpo | 1.17 | Evidence | |||||
TYK2 | TXK | TXK, PTK4: Tyrosine-protein kinase TXK | 1.17 | Evidence | |||||
TYK2 | ABL2 | ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 | 1.13 | Evidence | |||||
TYK2 | SLA2 | SLA2, C20orf156, SLAP2: Src-like-adapter 2 | 1.13 | Evidence | |||||
TYK2 | MATK | MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase | 1.13 | Evidence | |||||
TYK2 | LNK | SH2B3, LNK: SH2B adapter protein 3 | 1.13 | Evidence | |||||
TYK2 | RIN3 | N/A | 1.05 | Evidence | |||||
TYK2 | RIN1 | RIN1: Ras and Rab interactor 1 | 1.04 | Evidence | |||||
TYK2 | TESK1 | TESK1: Dual specificity testis-specific protein kinase 1 | 1.04 | Evidence | |||||
TYK2 | HLA-B | HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor | 1.03 | Evidence | |||||
TYK2 | HLA-C | HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor | 1.03 | Evidence | |||||
TYK2 | PLEK | PLEK, P47: Pleckstrin | 1.03 | Evidence | |||||
TYK2 | HLA-A | HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor | 1.03 | Evidence | |||||
TYK2 | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 1.01 | Evidence |